ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,166Medicare Part D Prescriptions Filled, Including Refills

Rank: 63 out of 1278

$536K Total Retail Price of All Prescriptions

Rank: 105 out of 1278

659 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
10% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arizona
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 659 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

8% of this provider’s 659 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

3% of this provider’s 10,085 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

15% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$48 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arizona
LEVOTHYROXINE SODIUM 636 596 1 2
SIMVASTATIN 598 552 2 3
OMEPRAZOLE 384 355 3 6
METFORMIN HCL 349 315 4 4
AMLODIPINE BESYLATE 335 327 5 5
ATENOLOL 307 284 6 11
ENALAPRIL MALEATE 299 268 7 58
LOSARTAN POTASSIUM 290 275 8 19
LISINOPRIL 283 244 9 1
ZOLPIDEM TARTRATE 259 235 10 16
METOPROLOL TARTRATE 201 190 11 9
HYDROCODONE-ACETAMINOPHEN 199 165 S3 12 7
WARFARIN SODIUM 195 178 13 17
PRAVASTATIN SODIUM 192 174 14 14
FLUOXETINE HCL 177 155 15 41
GLIPIZIDE 167 159 16 35
FUROSEMIDE 167 157 16 10
ALENDRONATE SODIUM 160 148 18 18
POTASSIUM CHLORIDE 154 150 19 21
PANTOPRAZOLE SODIUM 148 129 20 34
HYDROCHLOROTHIAZIDE 141 129 21 8
PAROXETINE HCL 140 135 22 56
GABAPENTIN 139 136 23 12
TRIAMTERENE-HCTZ 130 105 24 43
ATORVASTATIN CALCIUM 129 119 25 15
METOPROLOL SUCCINATE 124 121 26 23
LOVASTATIN 111 111 27 13
RANITIDINE HCL 100 91 28 20
AMITRIPTYLINE HCL 92 88 R 29 55
ALLOPURINOL 91 82 30 36
GEMFIBROZIL 87 73 31 54
CITALOPRAM HBR 85 60 32 22
TERAZOSIN HCL 82 82 33 59
FENOFIBRATE 79 55 34 47
INSULIN SYRINGE 73 70 35 50
PLAVIX 71 62 36 64
OXYBUTYNIN CHLORIDE 70 68 37 80
SERTRALINE HCL 65 58 38 28
LIPITOR 63 53 39 95
ADVAIR DISKUS 63 62 39 49
ENDOCET 61 48 S2 41 122
ESTRADIOL 61 58 R 41 71
CLOPIDOGREL 57 54 43 45
FORTICAL 55 55 44 269
PREMARIN 55 55 R 44 119
FLUTICASONE PROPIONATE 53 46 46 24
NOVOLOG 52 39 47 118
DOXAZOSIN MESYLATE 52 52 47 69
TRAZODONE HCL 51 43 49 38
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.